PureTech Health (PureTech Health) Additional Paid-In Capital : $290.26 Mil(As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is PureTech Health Additional Paid-In Capital?

PureTech Health's quarterly additional paid-in capital increased from Dec. 2022 ($289.62 Mil) to Jun. 2023 ($290.26 Mil) but then stayed the same from Jun. 2023 ($290.26 Mil) to Dec. 2023 ($290.26 Mil).

PureTech Health's annual additional paid-in capital increased from Dec. 2021 ($289.30 Mil) to Dec. 2022 ($289.62 Mil) and increased from Dec. 2022 ($289.62 Mil) to Dec. 2023 ($290.26 Mil).

PureTech Health Additional Paid-In Capital Historical Data

The historical data trend for PureTech Health's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health Additional Paid-In Capital Chart

PureTech Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

287.96

288.98

289.30

289.62

290.26

PureTech Health Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															289.30	289.30	289.62	290.26	290.26

PureTech Health Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

PureTech Health Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PureTech Health's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

PureTech Health (PureTech Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (OTCPK:PTCHF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

PRTC:USA PRTCl:UK PRTC:UK PRTCL:Germany

Address

6 Tide Street, Suite 400, Boston, MA, USA, 02210

Website

https://www.puretechhealth.com

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.